The Gastrointestinal Masterclass 1 has been one of our signature programs. It has received tremendous feedback and changed much of how gastrointestinal conditions are treated by many natural clinicians. This program was last broadcast live in early 2014 so is well due for an update. It is now a new program with new topics and several new presenters which is why we have called it The Gastrointestinal Masterclass 3.
The Gastrointestinal Masterclass 3 covers the foundation aspects of gut flora and function. We address eubiosis and dysbiosis, digestion and maldigestion, prebiotic fibres and foods, and probiotics.
Probiotics is a constantly advancing field with new understandings and therapeutic options arising frequently. An example is the recognition of the value of transient bacterial populations. These have beneficial effects whilst present in the gut but they don’t stay for long, although their effects may. A newly discovered feature of the transient bacterial populations is that they induce bacterial diversity in the gut. With the falling diversity we find in human populations the effect of transient bacteria may be substantial.
As well as updating the fundamentals of gastro function we cover several pathologies. The Gastrointestinal Masterclass 3 has a general focus on upper GI. We look at gastritis and oesophagitis, and also update the diagnosis and treatment options for Blastocystis, Giardia, and gastroenteritis.
This Masterclass is a must do update on the foundation of natural medicine – the gut. Keeping up with the advances in this area ensures that you are addressing one of the most common causes of most acute and chronic diseases.
Each of your presenters has been chosen because of their specialty and experience in their topics. They have considerable expertise and will give you what you need to make better clinical decisions and thereby achieve better patient outcomes.
Kiran Krishnan is a microbiologist, he has a deep understanding of microbial science and has spent the last 6 years studying microbial strains. He comes from a strict research background having spent several years with hands-on R&D in the fields of molecular medicine and microbiology at the University of Iowa.